Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT03518502
Eligibility Criteria:
Inclusion Criteria:
* Patients with hepatocellular carcinoma by the European Association for the Study of the Liver (EASL) criteria or pathology
* One or more extrahepatic metastatic lesion by proven radiologically or histologically
* No serious coagulation abnormalities
* Performance status 0 or 1 by Eastern Cooperative Oncology Group(ECOG) criteria
* Child-Pugh score 5 or 6
* Serum creatinine \<1.5mg/dL
* Age between 18 \~ 75 years old
* No other life-threatening medical illness
Exclusion Criteria:
* Patients with main portal vein invasion
* Child-Pugh class B or C
* History of TACE or previous systemic chemotherapy including sorafenib
* Age \>75 years old
* Cardiovascular diseases
* History of gastrointestinal bleeding within 2 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03518502
Study Brief:
Protocol Section:
NCT03518502